Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
Crossref DOI link: https://doi.org/10.3389/fphar.2019.00310
Published Online: 2019-03-29
Update policy: https://doi.org/10.3389/crossmark-policy
Hampel, Harald
Goetzl, Edward J.
Kapogiannis, Dimitrios
Lista, Simone
Vergallo, Andrea
Version of Record valid from 2019-03-29